Living with Long QT Syndrome: One Woman's Journey
"Adele Johnson shares her personal experience of diagnosis, treatment, and coping with Long QT syndrome, offering hope and information to others."
Imagine the relief of finally knowing what's wrong after experiencing unexplained and frightening symptoms. That was Adele Johnson's experience when she was diagnosed with Long QT syndrome (LQTS). However, relief quickly turned to fear as she faced a condition she had never heard of before.
For 27 years, Adele lived an active life, unaware that she had LQTS. Many people go undiagnosed for years because identifying triggers and understanding limitations is challenging. This is a potentially life-threatening condition.
Adele's journey began in August 2009 after a car accident triggered palpitations and dizziness. These symptoms led to anxiety and panic attacks, dramatically changing her life. Her story highlights the importance of awareness, early diagnosis, and finding effective coping strategies for those living with LQTS.
What Long QT Syndrome Means
Long QT syndrome (LQTS) involves a prolonged QT interval on an electrocardiogram (ECG), the tracing of the heart’s electrical activity. The New England Journal of Medicine describes the syndrome as carrying a propensity for potentially life-threatening arrhythmias. The NHLBI explains that “long QT” refers to an abnormal pattern on an ECG, which records the heart’s electrical activity. The sources provided do not give prevalence or population-impact statistics.
Diagnosis and Individualized Decisions
The Merck Manual describes LQTS as arising from congenital or acquired disruption of cardiac ion-channel function or regulation, prolonging the rate-corrected QT interval on an ECG. It notes that patients may be at risk for torsades de pointes, a polymorphic ventricular tachycardia that may stop spontaneously. Medscape likewise characterizes LQTS by prolonged QT on ECG and a risk of ventricular tachyarrhythmias that can lead to syncope, cardiac arrest, or sudden death. Published guidelines can inform care, but a commentary based on 24 LQTS clinicians reports that applying them to individual patients—especially those at intermediate risk—can be difficult.
From Early Cases to ECG Recognition
The first report of long QT syndrome dates to 1856, when German obstetrician and pediatrician Friedrich Ludwig Meissner described a deaf child who died after being publicly reprimanded by a schoolteacher. The European Heart Journal account says it took nearly a century for the first electrocardiogram showing a prolonged QT interval to be documented. A historical review places LQTS among congenital or acquired disorders associated with a prolonged QT interval and risk of malignant arrhythmias, while noting that understanding of congenital and acquired disease forms differs.
Understanding Long QT Syndrome
Long QT syndrome is a rare heart condition affecting the electrical system of the heart. While the heart's mechanical function remains normal, LQTS can cause a dangerously fast heart rhythm called Torsade de Pointes. This arrhythmia prevents the heart from effectively pumping blood, leading to oxygen deprivation in the brain.
- Type 1 and 2: Problems with potassium channels, often triggered by exercise or high emotional stress.
- Type 3: A sodium channel issue, potentially triggered by low heart rates during sleep or rest.
Current Reviews and Clinical Impact
A 2024 comprehensive review characterizes LQTS as a rare cardiac disorder involving prolonged ventricular repolarization and increased risk of ventricular arrhythmias, and summarizes knowledge of its pathogenesis and treatment strategies. A Gitxsan-perspective article notes that a prolonged QTc interval can predispose to ventricular arrhythmia presenting as syncope, seizures, or cardiac arrest. A February 2026 letter concerning a New England Journal of Medicine review says infectious diseases received limited attention in its discussion of congenital and acquired LQTS.
Evidence and Uncertainty
A qualitative study of coping with increased risk of sudden cardiac death conducted in-depth interviews with seven people who had been tested for an LQTS genetic mutation. Separately, the prospective, observational, multinational LIVE-LQTS study of vigorous exercise in congenital LQTS reported that confidence intervals were wide, consistent with a low event rate, and that noninferiority was not demonstrated. These findings indicate limits in what the supplied evidence can establish; the study snippet does not support a conclusion that vigorous exercise is proven safe or unsafe.
Pregnancy Risk and Inherited Mechanisms
A review of LQTS management in women before, during, and after pregnancy reports that cardiac events occurred at a rate of 0.8% among women treated with β-blockers, compared with 3.7% among women who were not treated. It recommends continued β-blocker therapy through the postpartum period for high-risk women, describing it as first-line protective therapy whose benefits outweigh treatment risks. A separate review describes primary genetic LQTS, also called Romano–Ward syndrome, as a rare but relevant inherited arrhythmia in which more than two decades of translational research have advanced understanding of normal and impaired myocellular repolarization.
Finding Strength and Support
After her diagnosis, Adele wondered if she had caused her condition through lifestyle choices. This led to a period of reflection and a desire to understand and manage her health effectively. Although the initial answer of 'Nothing' was very upsetting.
Expertise, Measurement, and Pregnancy Care
A 2023 commentary reports that, in a set of four ECGs from two LQTS cases, 50% of cardiologists and 20% of arrhythmia experts calculated the QTc incorrectly. This highlights a measurement challenge relevant to recognizing LQTS. Another commentary estimates a moderate risk of arrhythmias with hemodynamic compromise for mothers during labor and delivery, and calls for additional surveillance, including a pregnancy heart team experienced in inherited arrhythmia syndromes and careful heart-rhythm monitoring.
Treatment Market Outlook
The Business Research Company’s 2026–2030 Long QT Syndrome Treatment Market Trends Report describes LQTS treatment as management of arrhythmia intended to prevent life-threatening irregular heart rhythms that can lead to sudden cardiac arrest or death. The supplied snippet does not include market-size figures, growth estimates, or specific future therapies. It therefore supports a description of the treatment market’s stated purpose, but not a quantified forecast.
Beta-Blockers and Trigger Management
A systematic review of congenital LQTS identifies beta-blockers as a first-line therapy option. It says they address a common trigger for major cardiac events: a sudden increase in sympathetic activity, which it describes as mainly predominated by the left cardiac sympathetic nerves. The supplied source snippet does not provide further comparative treatment outcomes or details about access to care.
Turning her experience into a positive force, Adele became an advocate for healthy lifestyles, particularly among young people. She partnered with the British Heart Foundation (BHF) to raise awareness and funds, organizing a 'Heart Disco' to educate and support others.
Adele's journey demonstrates that living with Long QT syndrome requires ongoing management, support, and a proactive approach to health. While anxiety and concerns may linger, focusing on what you can do and maintaining a strong support network can empower you to live a full and active life.